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Porphyromonas gingivalis is a major periodontal pathogen that has pathogenic 
proteinases, Arg-specific gingipain and Lys-specific gingipain.  We previously found that 
a cell surface component on P. gingivalis is able to induce TLR2- and TLR4-independent 
signaling in 7.19 cells and that this component can be degraded by gingipains.  In this 
study, we purified this component from the P. gingivalis gingipain-null mutant KDP136 and 
obtained two candidate proteins.  MALDI-TOF MS analysis showed that the proteins with 
molecular masses of 123 and 43 kDa were encoded by PGN_0748 and PGN_0728 (pgm6), 
respectively, in the P. gingivalis ATCC 33277 genome sequence.  The 
PGN_0748-encoding protein, which we refer to as the gingipain-sensitive ligand A (GslA), 
reacted with antiserum that could effectively inhibit the activity of KDP136 to induce 
NF-B activation in 7.19 cells, but Pgm6 did not.  To further determine what protein is 
responsible for the NF-B activation, we constructed gslA, pgm6 and pgm6 pgm7 deletion 
mutants from KDP136.  When 7.19 cells were exposed to those mutants, the gslA deletion 
mutant did not induce NF-B activation, whereas the pgm6 and pgm6 pgm7 deletion 
mutants did.  Furthermore, NF-B activation in 7.19 cells induced by KDP136 was 


partially inhibited by antiserum against a recombinant protein from a 5’-terminal one third 
region of gslA.  These results indicate that GslA is one of the factors to induce NF-B 
activation in 7.19 cells.  Interestingly, the gslA gene was present in 4 of 7 P. gingivalis 
strains tested.  This restricted distribution might be associated with the virulence potential 





Porphyromonas gingivalis is an anaerobic Gram-negative bacterium that is 
frequently isolated from advanced periodontal lesions (25).  The number of P. gingivalis 
cells is closely associated with the depth of periodontal pockets and is significantly reduced 
after treatment (7).  Thus, this organism is thought to play an important role in the 
development and progression of periodontitis.  
P. gingivalis has two major cysteine proteinases, Arg-specific gingipain and 
Lys-specific gingipain.  These proteinases have been reported to cleave various host 
immune effector molecules, such as immunoglobulin (Ig) G and IgM (22), several 
cytokines and cytokine receptors (1, 2, 10, 11, 17), and a pattern recognition receptor, 
CD14 (21, 23).  Those modifications of host immune regulatory molecules enable P. 
gingivalis to escape from the host immune system.  This activity of gingipain seems to 
play an important role in the colonization of P. gingivalis in the oral cavity.   
Besides degradation of the host molecules, we previously found that gingipains 
could degrade a ligand expressed on the P. gingivalis cell surface (8).  A CHO cell-derived 
nuclear factor (NF)-B reporter cell line, 7.19, was stimulated with wild-type (ATCC 


33277) and gingipain-deficient P. gingivalis (KDP136) bacterial cells.  Since bacterial 
cells possess a number of ligands for Toll-like receptor (TLR) 2 and TLR4, 7.19 cells, 
which lack both TLR2- and TLR4-signaling pathways, enable analysis of TLR2- and 
TLR4-independent signaling (18).  Interestingly, 7.19 cells were activated by 
gingipain-null mutant KDP136 but not by its parental strain ATCC 33277, suggesting that 
the ligand of P. gingivalis was degraded by gingipains in the wild-type bacterial cells.  In 
fact, the ability of KDP136 to induce activation of NF-B in 7.19 cells was diminished after 
treatment of the bacterial cells with gingipains.  In a previous study (8), we partially 
purified components with the ability to activate NF-B in 7.19 cells from KDP136.  The 
activity of the components was also diminished by treatment with gingipains.        
The aim of the present study was to purify and identify the gingipain-sensitive 
ligand from gingipain-deficient P. gingivalis cells.  We tried further purification and 
obtained two proteins encoded by the protein coding sequence (CDS) PGN_0748 and the 
CDS PGN_0728 (pgm6) in the P. gingivalis ATCC 33277 genome sequence (14).  We then 
constructed CDS mutants from KDP136 and determined which protein is responsible for 
the activity to induce NF-B activation in 7.19 cells.  






     PBS, Ham’s F-12, penicillin-streptomycin and trypsin-EDTA were obtained from 
Life Technologies (Rockville, MD).  Fetal bovine serum was obtained from JRH 
Biosciences (Lenexa, KS).  Hygromycin B was obtained from Calbiochem (San Diego, 
CA).  DEAE Sepharose CL-6B and Superose 6 gel filtration columns were obtained from 
GE Healthcare (Buckinghamshire, UK).  Anti-CD25 monoclonal antibody conjugated 
with fluorescein isothiocyanate (FITC) was obtained from Becton Dickinson (Bedford, 
MA).  IgG1-FITC isotype control from murine myeloma was obtained from 
Sigma-Aldrich (St. Louis, MO).  The DNA primers used in this study are summarized in 
Table 1. 
 
Cell lines and flow cytometric analysis.  
 
The engineering of the CHO/CD14 reporter cell line has been previously described 


in detail (3).  The 7.19 cell line is a CHO/CD14 cell line-derived mutant that has a point 
mutation at position 284 of the coding region of MD-2 resulting in conversion of the codon 
for cysteine to tyrosine (18).  Therefore, this cell line is defective in both TLR4- and 
TLR2-signaling pathways but can express a reporter molecule, CD25, on the cell surface 
through NF-B activation induced by IL-1 (8).  This cell line was grown in Ham’s F-12 
supplemented with 10% fetal bovine serum and hygromycin B (400 U/ml) as adherent 
monolayers at 37˚C in a 5% CO2 atmosphere. 
For flow cytometric analysis, 7.19 cells were plated in 24-well tissue culture dishes 
at a density of 2.0 !105 cells per well.  After incubation for 20 h, a confluent monolayer 
of 7.19 cells was stimulated with freeze-dried bacteria (200 g/ml).  Following incubation 
for 20 h, the cells were treated with 30 mM EDTA for 1 min, and detached cells were 
assessed by flow cytometry for the presence of surface CD25 as described previously (8). 
 
Bacterial strains and culture conditions. 
 
     P. gingivalis ATCC 33277 and its isogenic mutants used in this study are shown in 
Table 2.  The cells were grown anaerobically (10% CO2, 10% H2, 80% N2) at 37˚C in 


enriched brain heart infusion medium supplemented with vitamin K1 (1 µg/ml) and hemin 
(5 µg/ml).  For maintenance of KDP136, erythromycin (10 µg/ml) was added to the 
medium.  For maintenance of the other antibiotic-resistant strains of P. gingivalis, 
erythromycin (10 µg/ml) and ampicillin (10 µg/ml) were added to the medium.  For 
reporter cell stimulation experiments, the microorganisms were harvested by centrifugation, 
washed three times with distilled water, and freeze-dried. 
 
Purification of the cell surface component from KDP136. 
 
      The cell surface component of KDP136 was partially purified as described 
previously (8).  Then further purification was carried by gel filtration chromatography 
(Superose 6 gel filtration column, 1.0 cm ! 30 cm, 24 ml column volume) at a flow rate of 
0.4 ml/min with 50 mM potassium phosphate buffer (pH 7.4) containing 0.05% CHAPS 
and 0.5 M NaCl.  Proteins in each fraction were analyzed by SDS-PAGE, and the activity 
of each fraction to induce NF-B activation was determined using 7.19 reporter cells.  
 




Proteins separated by SDS-PAGE were analyzed by matrix-assisted laser desorption 
ionization-time-of-flight mass spectrometry (MALDI TOF MS).  After in-gel tryptic 
digestion, peptides were extracted, concentrated, and analyzed using a Voyage-DE STR 
BioSpectrometry work station (Applied Biosystems, Foster City, CA).  The identities of 
the proteins were deduced from MS peaks via the MS-Fit peptide mass fingerprinting 




     To obtain antiserum against the ligand of P. gingivalis which can activate 7.19 cells, 
BALB/c mice were immunized with 30-250 µg of the partially purified components from 
KDP136 in conjunction with Freund’s incomplete adjuvant.  The immunization was 
performed at two-week intervals, with blood being collected from the tail vein every two or 
three times of injection.  The serum was tested for inhibitory activity to induce NF-B 
activation in 7.19 cells stimulated with KDP136.  
     To obtain a polyclonal antibody against PGN_0748-encoding protein which was 


designated the gingipain-sensitive ligand A (GslA), rabbits were immunized with 250µg of 
the recombinant protein in conjunction with Freund’s incomplete adjuvant.  The 
immunization was performed at two-week intervals, with blood being collected every two 
or three times of injection.  The antibody levels in the serum were measured by ELISA.  
     Following elevation of the titer of serum antibody, animals were boosted with another 
immunization, which resulted in antisera.  Animal care and experimental procedures were 
conducted in accordance with the Guidelines for Animal Experimentation of Nagasaki 
University and with approval of the Institutional Animal Care and Use Committee.  Rabbit 
polyclonal antibody was purified from antiserum using protein A-conjugated Sepharose 4B 
(GE Healthcare).   
 
Subcellular fractionation of P. gingivalis. 
 
      P. gingivalis at mid-log phase was subjected to the following fractionation as 
described previously (12).  Briefly, the cells were harvested by centrifugation at 10,000 ! 
g for 20 min and washed twice with 10 mM HEPES buffer (pH 7.4), suspended with 10 
mM HEPES buffer (pH 7.4) including 1 mM TLCK and 1 mM leupeptin, and disrupted in a 


French pressure cell at 100 MPa.  Unbroken cells and large debris were removed by 
centrifugation at 1,000 ! g for 10 min and the supernatants (whole cell lysates) were 
subjected to ultracentrifugation at 100,000 ! g for 1 h.  The precipitates were suspended in 
10 mM HEPES buffer (pH 7.4) supplemented with Triton X-100 at the final concentration 
of 1% and mixed gently at room temperature for 30 min.  The solution was subjected to 
ultracentrifugation at 100,000 ! g for 1 h to yield the bacterial outer membrane fraction as 
precipitates. 
 
Construction of P. gingivalis mutants. 
 
To construct a gslA deletion mutant, two DNA fragments corresponding to the 
upstream and downstream regions of gslA were polymerase chain reaction (PCR)-amplified 
from the chromosomal DNA of P. gingivalis ATCC 33277 with two primer pairs, 
0748UPFOR/0748UPREV and 0748DOFOR/0748DOREV.  Both DNA fragments were 
annealed and subjected to PCR amplification with the primers 0748UPFOR and 
0748DOREV.  The resulting amplified fragment in which gslA was replaced with BamHI 
site was ligated to the pCR4Blunt-TOPO vector (Invitrogen, Carlsbad, CA), resulting in 


pKD1001.  The ampicillin resistance gene cepA was amplified from pCS22 with two 
primers, CEPFOR and CEPREV, and inserted into the BamHI site of pKD1001, resulting in 
a gslA deletion cassette, pKD1002.  KDP136 was transformed to be ampicillin-resistant by 
electroporation with linearized pKD1002 plasmid DNA to yield a gslA deletion mutant, 
KDP377 (kgp-2::cat rgpA2::[ermF ermAM] rgpB2::tetQ gslA::cepA).  
To construct pgm6 and pgm6 PGN_0729 (pgm7) deletion mutants, DNA fragments 
corresponding to an upstream region of pgm6 was PCR-amplified with the primers 
0728UPFOR and 0728UPREV.  A downstream fragment of pgm6 was PCR-amplified 
with the primers 0728DOFOR and 0728DOREV.  A downstream fragment of pgm7 was 
PCR-amplified with the primers 0729DOFOR and 0729DOREV.  Each resulting amplified 
fragment was ligated to the pCR4Blunt-TOPO vector.  The vector containing the upstream 
fragment of pgm6 was digested with NotI and BamHI and the other vectors were digested 
with BamHI and EcoRI. The NotI-BamHI fragment, BamHI-EcoRI fragment, and 
pBluescript SK(-) vector (Stratagene, La Jolla, CA) digested with NotI and EcoRI were 
ligated, resulting in pKD1003 (pgm6-target) and pKD1004 (pgm6 pgm7-target).  The 
amplified cepA gene was inserted into the BamHI site of pKD1003 or pKD1004, resulting 
in a pgm6 deletion cassette, pKD1005, or a pgm6 pgm7 deletion cassette, pKD1006.  Each 


cepA-inserted plasmid was subjected to transformation of KDP136 to yield a pgm6 deletion 




Recombinant GslA protein was prepared as described previously (15).  The DNA 
fragment coding for the 5’-terminal 510 amino acids was amplified from gslA of P. 
gingivalis ATCC 33277 with two primers, GSLAFOR1 and GSLAREV1.  Resulting 
fragments were then inserted into the NdeI-EcoRI site of pET22b plasmid to yield 
pKD1007.  E. coli BL21 (DE3) harboring resulting plasmids were grown in LB broth.  
Then isopropyl -D-thiogalactoside was added to the culture at 0.1 µM followed by 
incubation for 2 h to overproduce the recombinant protein.  The induced recombinant 
protein was purified by the Ni-NTA purification system (Invitrogen). 
 
Western blot analyses.  
 
The samples were dissolved in Laemmli sample buffer and separated by SDS-PAGE.  


The gels were stained with Coomassie brilliant blue (CBB) or transblotted onto 
Immun-Blot PVDF membranes (Bio-Rad Laboratories, Hercules, CA).  Each membrane 
was blocked with 5% skim milk in PBS for 2 h at room temperature (RT) and reacted with 
the mouse polyclonal antibody against the Triton X-114-extracted bacterial cell surface 
components or the rabbit polyclonal antibody against the recombinant protein from a 
5’-terminal one third region of gslA in 5% skim milk in PBS for 2 h at RT.  Each 
membrane was then washed with PBS containing 0.05% Tween 20 and subjected to 
immunodetection using peroxidase-conjugated goat anti-mouse Ig or peroxidase-conjugated 
swine anti-rabbit Ig and an ECL plus detection system (GE Healthcare).   
 
Southern hybridization analyses. 
 
DNA probe for the upstream region of gslA was prepared with PCR-amplification 
from ATCC 33277 chromosomal DNA using the primer pair 0748UPFOR and 0748UPREV.  
DNA probe for cepA was prepared with PCR-amplification from pCS22 plasmid DNA 
using CEPFOR and CEPREV.  Three DNA probes for internal regions of gslA were 
prepared with PCR-amplification from ATCC 33277 chromosomal DNA with three primer 


pairs.  DNA probes a, b and c were prepared with GSLAFOR1 and GSLAREV1, 
GSLAFOR2 and GSLAREV2, and GSLAFOR3 and GSLAREV3, respectively.  These 
probes were labeled with the Alkphos Direct system for chemiluminescence (GE 
Healthcare).  Chromosomal DNA was digested with BamHI or PstI, electrophorased in a 
0.8% agarose gel.  Southern blotting was performed using a Hybond-N+ membrane (GE 






Purification and identification of the protein from KDP136 that induces NF-B 
activation in 7.19 reporter cells. 
The bacterial cell surface components of P. gingivalis KDP136 extracted with Triton 
X-114 were subjected to ion exchange chromatography as described previously (8).  They 
were further purified by gel filtration chromatography and the resulting fractions were 
analyzed for the activity to induce NF-B activation in 7.19 cells.  The fractions with high 
activity were subjected to SDS-PAGE, and a 43-kDa protein and a 123-kDa protein were 
detected (Fig. 1A).  The 123-kDa protein was found in the Triton X-114-extracted 
bacterial cell surface components of KDP136 but not in those of P. gingivalis ATCC 33277.  
MALDI-TOF MS analysis revealed the 123-kDa and the 43-kDa proteins as proteins 
encoded by PGN_0748 and PGN_0728 (pgm6), respectively.  PGN_0748 consists of 
1,530 amino acids, and the peptides of the 123-kDa protein obtained by MALDI-TOF MS 
analysis were matched to the amino acid sequence in the region from A38 to R1219 of 
PGN_0748, indicating that the 123-kDa protein was at least encoded by the 5’-terminal 3/4 
region of PGN_0748-encoding gene without the putative signal peptide-encoding region 


(Fig. 2).  
Western blot analyses were performed using mouse antiserum that was obtained by 
immunization of the Triton X-114-extracted bacterial cell surface components and could 
effectively inhibit NF-B activation in 7.19 cells stimulated with KDP136.  The antiserum 
reacted to the 123-kDa protein but not to the 43-kDa protein (Fig. 1B).  The antiserum 
also reacted to a protein with a molecular mass of 40 kDa in lane 2 (ATCC 33277).  Since 
the 40-kDa protein seems not to be present in the cell surface components extracted from 
KDP136, the protein may be a protein product degraded from the 123-kDa protein.  These 
results suggested that the 123-kDa protein, which we refer to as the gingipain-sensitive 
ligand A (GslA), was a principle candidate for the ligand to induce NF-B activation in 
7.19 cells.     
 
Responses of 7.19 cells to gslA, pgm6 and pgm6 pgm7 deletion mutant cells. 
To determine which protein is responsible for the induction of NF-B activation in 
7.19 cells, GslA-encoding gene (gslA), pgm6 and pgm6 pgm7 deletion mutants (KDP377, 
KDP378 and KDP379, respectively) were constructed from the gingipain-null mutant 
KDP136 (rgpA rgpB kgp).  Since proteins encoded by pgm6 and pgm7 form stable 


heterotrimers (13), we constructed the pgm6 pgm7 mutant (KDP379) to exclude the 
possibility that the function of those heterotrimers was substituted by the homotrimer of 
Pgm7.  Each target gene was replaced by cepA, an ampicillin resistance gene.  The 
design for construction of the mutants is shown in Fig. 3A and B.  Correct construction of 
the mutants was revealed by Southern blot hybridization and PCR analyses (Fig. 3C and 
data not shown).    
      7.19 cells were stimulated with wild-type or mutant P. gingivalis cells and subjected 
to flow cytometric analysis.  Freeze-dried KDP136 cells induced a considerable level of 
NF-B activation in 7.19 cells, whereas ATCC 33277 induced only a marginal level of 
activation (Fig. 4A and B).  Cells of strain KDP377 showed a much lower level of NF-B 
activation than did cells of strain KDP136 (Fig. 4C).  Cells of strains KDP378 and 
KDP379 induced the same levels of CD25 expression as that induced by cells of strain 
KDP136 (Fig. 4D and E).  These results indicated that GslA was essential for the 
activation of NF-B in 7.19 cells.  
 
Western blot and inhibition assay by polyclonal antibody against recombinant 
GslA protein.  


A polyclonal antibody against the recombinant protein encoded by the 5’-terminal 
1/3 region of gslA was raised, and Western blot analysis was performed using this antibody.  
The antibody reacted to the 123-kDa protein in the whole cell lysates of ATCC 33277 and 
KDP136, but there were no protein bands in the lysate of KDP377.  In addition, the lysate 
of KDP136 contained a much larger amount of the 123-kDa protein than that in the lysate 
of ATCC 33277.  Similar results were obtained when outer membrane fractions were used.  
These results confirmed the identity of the 123-kDa protein and gslA product (Fig. 5A and 
B).  Next, an experiment was performed to determine whether this antibody could inhibit 
activation of NF-B in 7.19 cells induced by freeze-dried KDP136.  The activation of 
NF-B in 7.19 cells was partially inhibited by this antibody compared to the activation 
induced in the presence of the IgG fraction purified from the serum of a pre-immunized 
rabbit (Fig. 5C).  Together with the results of the genetic experiments, the results indicated 
that GslA was responsible for the activation of NF-B in 7.19 cells. 
 
Distribution of gslA among various strains of P. gingivalis  
Interestingly, the gslA gene is not found in the genome of P. gingivalis W83 (16).!
A DNA region (7.7 kb) containing gslA of the ATCC 33277 genome between direct repeats 


(TTTTATAA) was deleted in the W83 genome (Fig. 6A).  To investigate the presence of 
gslA in other P. gingivalis strains, Southern blot analysis was performed.  Three probes for 
gslA hybridized to the genomic DNA from P. gingivalis strains ATCC 33277, TDC117, 





We purified cell surface components of KDP136 and found two proteins with 
molecular masses of 123 and 43 kDa in the cell surface components with high ability to 
induce NF-B activation in 7.19 cells.  In Western blot analysis, mouse antiserum that 
could inhibit the activation of NF-B in 7.19 cells reacted to the 123-kDa protein but not to 
the 43-kDa protein.  When 7.19 cells were stimulated with freeze-dried P. gingivalis, a 
gslA deletion mutant lacking the 123-kDa protein did not induce NF-B activation in 7.19 
cells, whereas a pgm6 or pgm6 pgm7 deletion mutant lacking the 43-kDa protein induced 
NF-B activation.  These results all indicate that the 123-kDa protein encoded by gslA is a 
crucial factor for inducing NF-B activation in 7.19 cells. 
       The polyclonal antibody against the 123-kDa protein partially inhibited the 
activation of NF-B in 7.19 cells induced by freeze-dried KDP136, indicating that the 
123-kDa protein was involved in the induction of NF-B activation in 7.19 cells.  The 
partial inhibition might be due to the existence of another gingipain-sensitive ligand that 
could induce NF-B activation in 7.19 cells.  In accordance with this hypothesis, 
stimulation with the gslA deletion mutant induced a slightly higher level of NF-B 
activation in 7.19 cells than that induced by stimulation with the wild-type strain.  


      The lysate of the gingipain-null mutant KDP136 contained a much larger amount of 
the 123-kDa protein than that in the lysate of the wild-type strain ATCC 33277.  In 
addition, the Triton X-114-extracted cell surface protein fraction of ATCC 33277 had no 
123-kDa protein, whereas that of KDP136 did have the 123-kDa protein.  It is likely that 
the 123-kDa protein was degraded by surface-associated gingipains after transportation of 
the protein to the cell surface in the wild-type P. gingivalis.  The degradation of the 
123-kDa protein on the cell surface of wild-type P. gingivalis is consistent with the findings 
by other investigators that gingipains cleave and process the products encoded by fimA, 
mfa1, rgpA, rgpB, kgp, hagA and ragA genes, which are located on the bacterial cell surface 
(5, 12, 24).  Masuda et al. reported that the expression of mRNA for gingipains is 
modulated by environmental stress (9).  Expression and activities of gingipains gradually 
decreased with the increase of growth rate of P. gingivalis.  Activities of gingipains in the 
culture fluids of P. gingivalis under aerated conditions were approximately eightfold lower 
than those in anaerobic conditions.  In those conditions, the 123-kDa protein may remain 
intact on the cell surface even in wild-type P. gingivalis cells and induce NF-B activation.    
      The physiological function of the 123-kDa protein encoded by gslA is unknown, and 
no homologue to GslA was found by BLASTP analysis.  Interestingly, gslA was found in 4 


of 7 strains of P. gingivalis.  Although strain W83 has been found to be more virulent than 
strain ATCC 33277 in a mouse subcutaneous chamber model, rats challenged with strain 
ATCC 33277 had more periodontal bone loss than those challenged with other strains (4, 6).  
Although further studies are needed to determine whether presence of gslA is influential in 
pathogenesis of P. gingivalis, the restricted distribution of gslA might be associated with the 
virulence potential of each strain.  The common features of the four strains possessing 
gslA could be a clue for finding the pathogenic function of GslA.    
     The 123-kDa protein could induce NF-B activation in 7.19 cells in a TLR2- and 
TLR4-independent manner.  Although the activity to induce NF-B activation was 
analyzed using only 7.19 cells, it is important to determine whether and how this ligand 
stimulates host cells derived from human periodontal tissue.  Suppose GslA is able to 
induce NF-B activation in periodontal tissue, it will lead to the secretion of 
proinflammatory cytokines and chemokines that promote the acceleration of inflammatory 
responses in periodontal tissue.  Regulation of gingipain expression by environmental 
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Figure 1.  SDS-PAGE and Western blot analyses of bacterial components.   
 
Cell surface components of P. gingivalis were extracted with Triton X-114 (lane 1, 
gingipain-null mutant KDP136; lane 2, wild-type ATCC 33277).  Then the cell surface 
components of KDP136 were purified by an ion-exchange chromatography and gel 
filtration chromatography as described in Materials and Methods, lane 3. Those samples 
were loaded on 15% SDS-PAGE and the gel was stained with Coomassie Brilliant Blue 
(CBB) (A) or subjected to Western blot analysis using mouse antiserum that could 
effectively inhibit NF-B activation in 7.19 cells stimulated with KDP136 (B).  
 
Figure 2.  MALDI-TOF-MS analysis of the 123-kDa protein. 
 
     The predicted peptides that matched to GslA are shown with underlines.   
 




gslA (A) and pgm6 alone or pgm6 pgm7 (B) were replaced with cepA genes as 
described in Materials and Methods.  Arrows show CDSs.  PGN numbers are CDS 
numbers of P. gingivalis 33277.  Hybridization probes for the upstream region of gslA 
(black box) and for cepA (gray box) are indicated (A).  ‘P’ indicates the restriction 
enzyme-recognized site for PstI.  Chromosomal DNA from gingipain-null mutant 
KDP136 and its gslA deletion mutant KDP 377 was digested with PstI and subjected to 
Southern hybridization using a probe specific for the upstream region of gslA (C-a) and a 
probe specific for cepA (C-b).  Lanes: 1, KDP136 (kgp rgpA rgpB); 2, KDP377 (kgp rgpA 
rgpB gslA::cepA). 
 
Figure 4. NF-B activation in 7.19 cells exposed to wild-type or mutant P. gingivalis.  
 
7.19 cells were stimulated with 200 µg/ml of freeze-dried wild-type P. gingivalis 
ATCC 33277 (A), gingipain-null mutant KDP136 (kgp rgpA rgpB) (B), gslA deletion 
mutant KDP377 (kgp rgpA rgpB gslA::cepA) (C), pgm6 deletion mutant KDP378 (kgp rgpA 
rgpB pgm6::cepA) (D), and pgm6 pgm7 deletion mutant KDP379 (kgp rgpA rgpB [pgm6 


pgm7]::cepA) (E).  Following 20 h of incubation, the cells were stained with FITC-labeled 
anti-CD25 monoclonal antibody (bold line) or isotype-matched control monoclonal 
antibody (dotted line) and subjected to flow cytometric analysis for NF-B-driven CD25 
expression.  Representative results of one of three experiments performed are shown.  
MFI is mean fluorescence intensity. 
 
Figure 5. Inhibition of KDP136-induced NF-B activation in 7.19 cells by an antibody 
against the recombinant GslA protein. 
 
Whole cell lysates and outer membrane fractions of P. gingivalis were subjected to 
7% gel SDS-PAGE and stained with CBB (A) or reacted with the polyclonal antibody 
against the recombinant protein encoded by the 5’-terminal 1/3 region of gslA (B).  
Arrows indicate the 123-kDa protein.  Lanes: 1, wild-type P. gingivalis ATCC 33277; 2, 
gingipain-null mutant KDP136 (kgp rgpA rgpB); 3, gslA deletion mutant KDP377 (kgp 
rgpA rgpB gslA::cepA).  (a) whole cell lysates, (b) outer membrane fraction. 
7.19 cells remained unstimulated (thin line) or were stimulated with 200 µg/ml of 
freeze-dried KDP136 bacterial cells in the presence of 100 µg/ml of the polyclonal 


antibody used for Western blot analysis (bold line) or the IgG fraction from serum of a 
pre-immunized rabbit (dotted line).  Following 20 h of incubation, 7.19 cells were stained 
with FITC-labeled anti-CD25 monoclonal antibody and subjected to flow cytometric 
analysis for NF-B-driven CD25 expression (C). Representative results of one of three 
experiments performed are shown.  MFI is mean fluorescence intensity.  
 
Figure 6.  Distribution of gslA among various strains of P. gingivalis. 
 
Hybridization probes for internal regions of gslA are indicated (A).  Detailed DNA 
sequences of an asterisk, a sharp, and a filled circle region were also indicated.  ‘B’ 
indicates the restriction enzyme-recognized site for BamHI.  Arrows show CDSs.  PGN 
numbers are CDS numbers of P. gingivalis ATCC 33277.  PG numbers are those of P. 
gingivalis W83.  Chromosomal DNA from ATCC 33277 and other strains of P. gingivalis 
was digested with BamHI and subjected to Southern hybridization using three probes 
specific for internal regions of gslA (B). Lanes: 1, P. gingivalis ATCC 33277; 2, W83; 3, 




TABLE 1. Bacterial strains, plasmids and oligonucleotides used in this study 
Strains Description Source or ref. 
P. gingivalis   
ATCC 33277 ATCC 
W83 





Gift from K. 
Ishiharab 
SU63 




Gift from E. 
Hoshinod 
KDP136 kgp-2::cat rgpA2::[ermF ermAM] rgpB2::tetQ (19) 
KDP377 kgp-2::cat rgpA2::[ermF ermAM] rgpB2::tetQ [gslA]::cepA This study 
KDP378 kgp-2::cat rgpA2::[ermF ermAM] rgpB2::tetQ [pgm6]::cepA This study 
KDP379 
kgp-2::cat rgpA2::[ermF ermAM] rgpB2::tetQ [ pgm6 
pgm7]::cepA 
This study 
E. coli   
XL-1 Blue General-purpose host strain for recombinant protein production Stratagene 
BL21(DE3) Host strain for production of recombinant proteins (20) 
Plasmids Description Source or ref. 
pCR4Blunt-TOPO Apr Kmr, plasmid vector for cloning Invitrogen 
pBluescript  
SK(+) 
Apr, plasmid vector for cloning Stratagene 
pET22b Apr, plasmid vector for cloning Novagenf 
pCS22 Apr, contains the cepA DNA cassette at AatII site of pCS14  Gift from E.C. 


  Reynoldse 
pKD1001 
Apr Kmr, contains 0.6 kb gslA-upstream and 0.9 kb 
gslA-downstream DNA fragments in pCR4BluntII-TOPO 
This study 
pKD1002 




Apr, contains 0.8 kb pgm6-upstream and 0.8 kb 
pgm6-downstream DNA fragments in pBluescript  SK(+) 
This study 
pKD1004 
Apr, contains 0.8 kb pgm6-upstream and 0.8 kb 
pgm7-downstream DNA fragments in pBluescript  SK(+) 
This study 
pKD1005 








Apr, contains the 5’-terminal one third of gslA DNA fragment 
in pET22b 
This study 























Restriction sites incorporated into oligonucleotides for subcloning are underlined.
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